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Resumen
Objetivo: Diseñar un modelo con criterios estadísticos 
adecuados para la predicción del costo médico de una 
Empresa Administradora de Planes de Beneficio (EAPB) en 
Salud.
Métodos: Estudio de corte transversal con seguimiento 
retrospectivo de la utilización de los servicios de salud en 
una EAPB durante un periodo de un año. El marco muestral 
lo constituyó una población de 1.529.188 afiliados que 
estaban asignados a un grupo de IPS de atención primaria. 
Por muestreo aleatorio simple, se estimó el tamaño en 
190,917 usuarios. La variable dependiente fue el costo de los 
servicios utilizados deflactados al año 2014. Como variables 
independientes, además de las tradicionales variables 
sociodemográficas escogidas en estos tipos de modelos 
de predicción, se agregaron variables del aseguramiento; 
variables de gestión de riesgo (inclusión o no en programa 
de promoción y prevención) y de comorbilidades.
Resultados: La modelación con Regresión Lineal Simple 
mostró errores de criterios del modelo inapropiados como 
el de violar el principio de la normalidad. Los Modelos 
Lineales Generalizados, propuestos para estimar los 
costos medios POS, tienen bondad de ajuste apropiadas 
y evaluadas con Devianzas pequeñas y criterio Akaike 
(AIC) mínimo comparado con otros modelos de la familia 
exponencial. 
Conclusiones: El modelo estadístico apropiado para predecir 
costos médicos fue el Modelo Lineal Generalizado a dos 
partes segmentados por grupos de edad y género. La presente 
investigación sugiere que para estimar la prima de beneficios 
de cualquier EAPB se utilicen además de las variables 
sociodemográficas, variables de aseguramiento, la pertenencia 
o no a programas de promoción y Prevención y/o gestión de 
riesgo y la carga de enfermedad de esa población.
Prediction of Medical Costs in a Health Insurance Carrier according to Risk Profiles and Uses 
by its Affiliates
Predicción del Costo Médico de una Empresa Administradora de Planes de Beneficio en Salud de acuerdo a 
los Perfiles de Riesgo y Uso de sus Afiliados
Rodolfo Herrera Medina1,3, Jaime Lee2,3, Ferney Herrera Cruz3
Abstract
Objective: To find a model of prediction of the medical cost 
of a Health Benefits Management Company (EAPB) with 
adequate statistical criteria.
Methods: A Cross-sectional study with retrospective follow-
up of the use of health services in an EAPB during a one-
year period. The sampling frame consisted of a population 
of 1,529,188 affiliates who were assigned to a primary care 
IPS group. By simple random sampling size was estimated 
at 190,917 users. The dependent variable was the cost of 
the services used deflated to the year 2013. As independent 
variables besides the traditional sociodemographic 
variables chosen in this type of prediction models, variables 
of the insurance were added; Variables of risk management 
(inclusion or not in promotion and prevention program) 
and of comorbidities.
Results: Simple Linear Regression modeling showed 
errors of inappropriate statistical criteria such as violating 
the principle of normality in cost errors. The Generalized 
Linear Models, proposed to estimate POS average costs, 
have an appropriate goodness of fit and evaluated with 
small Deviations and minimum Akaike criterion (AIC) 
compared to other models of the exponential family
Conclusions: The appropriate statistical model to predict 
medical costs was the Generalized Linear Model with two 
parts segmented by age groups and gender. This research 
suggests that to estimate the benefit premium of any EAPB, 
besides socio-demographic variables, insurance variables, 
membership or not in promotion programs and risk 
prevention and/or management and the burden of disease 
of that population should be used.
Key Study Facts
Objective To find a model of prediction of the medical cost of a Health Benefits Management 
Company (EAPB) with adequate statistical criteria.
Study design Cross-sectional with retrospective follow-up
Source of data Obligatory Health Plan health services of affiliates to an EPS during a one-year period
Population/Sample 1,529,188 affiliates who were assigned to a primary care IPS group. By simple random 
sampling size was estimated at 190,917 users
Statistical analysis Generalized Linear Regression modeling
The dependent variable was the cost of the services used deflated to the year 2013. As 
independent variables besides the traditional sociodemographic variables chosen in this 
type of prediction models, variables of the insurance were added; Variables of risk man-
agement (inclusion or not in promotion and prevention program) and of comorbidities
Main finding To estimate the benefit premium of any EAPB, besides socio-demographic variables, 
insurance variables, membership or not in promotion programs and risk prevention 
and/or management and the burden of disease of that population should be used
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Introduction
Estimating medical costs has been a concern in countries where 
services are offered through a mean fee. However, many of the 
estimations have been imprecise. Some countries, like Peru, 
have undertaken methodologies to try to estimate the standard 
costs of the medical procedures that will then be incorporated 
into the Universal Health Benefits Plan (1).
In Colombia, estimates have been made since 1993 of the 
medical cost that will be incurred during the following year by 
a population ensured with the General Social Security System 
(SGSS, for the term in Spanish), an estimation denominated: “ex 
ante approximation”, and legislatively called Capitation Payment 
Unit ”CPU”, articles 156 and 179 of Legislation 100 (2) and with 
which the health promoter entities (EPS o HMO) must manage the 
offer of the health services hiring the network that provides these 
services to the population ensured, article 205 of Legislation 100 
(2). The Ministry of Health traditionally, since 1994 to date, has 
calculated this fee by using simple linear regression models (SLR).
This work proposed the search for cost estimation models that 
include independent variables, like the age and gender of the 
affiliate, as has usually been done by the Colombian Ministry 
of Health, as well as the inclusion of variables associated with 
the health-disease status of each affiliate cared for. Likewise, 
it sought to propose modelling techniques different from the 
traditional, like the SLR models to estimate costs, and included 
other models until achieving an adequate one with satisfactory 
performance in the valuation of statistical goodness of fit 
indicators, like the case of generalized linear models (GLM). 
This type of model measures goodness of fit with a couple of 
indicators: the Deviance indicator, which may be understood as 
a measurement of the lack of information available in the model 
to explain the phenomenon of interest in the response variable 
(the smaller the better), and the Akaike Information Criterion 
(AIC), an indicator that in its calculation involves the Deviance 
penalized by the number of parameters involved in the model 
(the smaller the better). The first model estimated, SLR, did 
not fulfill the basic validation assumptions, like normality and 
homoscedasticity in the dependent variable, additionally, no 
adequate goodness of fit indicators were obtained, given that 
the R2 at most reached 6%. Thereafter, more robust estimation 
models were proposed, like the GLM applied in modelling two 
parts (estimating in the first part the probability of using the 
health services, and in the second part estimating the costs 
implied in said use), which has found considerable acceptance 
in the methodology of evaluating risks, thus, obtaining a general 
expenditure prediction for an individual, upon multiplying both 
predictions obtained from each part of the model (3,4).
This work sought to find an ex ante prediction model that, besides 
estimating the POS medical cost, complies with more robust or 
adequate statistical criteria to the traditional, as well as a search 
for predictive methodologies of the medical costs that can serve 
to monitor the costs of health services required by the users of a 
health insurer without having the prior invoicing and only having 
demographic factors, variables appertaining to the insurance 
business, and the user risk classification variable.
Methods
Epidemiological design
This was a cross-sectional study with a retrospective follow up of 
the POS health services of affiliates to an EPS during a one-year 
period.
Probabilistic models were used to analyze the estimate of 
medical costs defined in the Obligatory Health Plan (POS, for the 
term in Spanish) (5). A probabilistic sample was extracted from 
several geographic- administrative regions of an EPS from the 
contributive regime with which the model’s parameters were 
tested and, according to their health risk characteristics costs 
were estimated by regions and age range.
Sample design
The simple framework was the population cared for as a primary-
care IPS and who are managed by the same EPS to which they 
belong. This guaranteed the quality of the diagnoses, and the 
totality of the orders to provide medical services.
Inclusion and exclusion criteria
The study included affiliates who were compensated, see article 
205 of Legislation 100 of 1993 (1), at some moment for the 
period comprised between 01 October 2013 and 30 September 
2014. The work excluded those who did not have complete 
information or who had costs registered but not invoiced, or with 
evidence of the service not having been provided.
Calculation of simple size
The type of sampling used was stratified with proportional 
assignment through six geographic regions established to 
manage the affiliate population. The global sample was estimated 
at 190,917 people whose simple framework was constituted by 
1,529,188 users affiliated to the IPS which guaranteed the data 
on authorizations, clinical histories of the services provided and 
the costs of invoicing with transactional systems arranged by the 
EPS under its technological platform. Using for its estimation a 
standard deviation of the cost, according to historical data, at 
cop $ 5,900,000, 95% CI and a precision of cop$ 31,000 with an 
effect of the design of 1.50.
Statistical design
As dependent variable, it was available from the POS cost in 
Colombian pesos (cop$). The costs of 2013 were deflated to 
costs of 2014. Every user will have as constant monthly cost the 
cost paid according to hiring modality with capita, according to 
the CPU.
There were three types of independent variables: a. demographic 
factors; insurance factors: new in the EPS (less than six months 
affiliated), wage range (1 ≤ 2 SMLV; 2 = between 2 and 4 
SMLV; 3 ≤ 4 SMLV), type of affiliate (1 = Main contributor, 2 = 
Beneficiary, 3 = Additional or Secondary contributor), type of 
contributor (1 = Pensioner, 2 = Independent, 3 = dependent); 
c. factors of the offer: affiliates reported in Resolution 4505 
by the Ministry of Health (6), and with management of the 
health risk, users reported in the High-Cost Account - HCA (7), 
complementary plan (affiliated to a voluntary insurance plan or 
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pre-paid medical care), poly-consultant (having seven or more 
external consultations per year); d. factors of disease burden: 
classification of risks according to diagnoses from the CIE- 10 
(8) in nine groups (Low prevalence and high cost, oncological 
(excludes those identified in HCA as patients with cancer), 
chronic obstructive pulmonary disease (COPD), mental disease, 
maternal perinatal, cardiocerebral-renovascular (CCRV), chronic 
disease, acute disease, avoidable disease. The classification of 
Diagnostic Relational Groups (DRG) classifies users into one or 
several of the groups defined according to diagnoses registered 
during any contact with the health services for a given year.
Modelling began with an SLR and, thereafter, to a multiple linear 
regression with regressors, like age and gender. The regressor 
variables (independent variables) were included, with the “POS 
cost” being the dependent variable or response variable with the 
following equation:
                        [1]
Compliance was verified of the properties of homogeneity 
and normality in errors. However, due to prior and descriptive 
knowledge on the asymmetry in the distribution of costs (Figure 
1), the large amount of zeros (affiliates who incur no costs) 
and the long tails in the distribution, the asymmetry in the 
distribution of costs, lead to proposing models that explain this 
behavior (3), herein emerges the concept of two-part models 
(3,9). The final model is the product of both models, which 
conjugates frequencies and mean costs. Where the first part 
estimates the probability of an individual requesting a service, 
given their sociodemographic factors and disease burden where 
logistic regression models were used, one per segment of age 
and gender.
The second part estimates the value of the expected cost of the 
service given that a request for such is made (users), according to 
the sociodemographic factors of the affiliates and their disease 
burden; this last part of the model was conducted through 
generalized linear models (10-12). This second part of the model 
will be used to determine factors associated to costs. Although 
cross-sectional studies, the principal objective is to estimate 
the frequency of the health event; furthermore, the OR can be 
calculated as if it were a cases and controls study (13). Cross- 
sectional studies have been considered by some authors as cases 
and controls studies in which it is assumed that the time between 
the exposure and onset of the disease is null (14)
These models were evaluated according to the goodness of fit 
indicators that fulfill the statistical conditions required, so that 
interpretative value is added to the information and robustness 
upon changes of population structure, as well as with the 
sufficient financial conditions for a satisfactory application in the 
EPS.
Explanation of the GLM with Gamma and logarithmic link
                                   [2]
Results
Behavior of costs
To model the cost of service, a database was available with 
190,693 records of affiliates to the EPS from which 63,000 had 
no costs associated with health services (33%), 67% of the users 
had annual costs, only POS services, ranging from cop$ 26,000 to 
cop$ 284,249,547, which shows a highly variable behavior with 
a positive strongly asymmetric distribution, as noted in Figure 1.
The difference of the mean cost between men and women is not 
statistically significant (p = 0.066), but significant differences are 
noted by gender for groups from 15 to 18 years of age and from 
19 to 44 years of age (p = 0.000) (Figure 2). Additionally, it is 
observed how the mean cost, as well as its variance increases as 
the age of the population group increases.
In spite of the asymmetry of the costs, the simple linear regression 
model was applied with age as independent variable, giving the 
following results: Standard deviation = 3.238.940; R2 = 16.4%; 
R2 (adj) = 16.3%; and the errors are not distributed normally 
(Figure 3A). These results contradict the use of these types of 
statistical models when the dependent variable is the health 
costs. From the aforementioned, the need emerged to search 
for other statistical models that permit statistical validity to any 
Figure 1. POS cost slanted to the left
Figure 2. Differential behavior of POS costs, summarized through.
variation coefficients (VC) by age and gender segments
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study where costs behave asymmetrically, as is the case and as 
is manifested by Mihaylova (9) in the form of “inconsistent or 
inefficient results” (15) under this analysis category of the costs 
of health care.
The behavior described led to testing some transformations on the 
dependent variable to try to stabilize the variance. After diverse 
transformation explorations, the logarithmic transformation was 
chosen, which helps to smooth the variance of the residuals. The 
multiple regression model was then used with all the variables, 
eliminating those that were highly correlated, and those that 
did not contribute greatly to the model, and considering as 
dependent variable the Natural Logarithm of the POS cost. The 
R2 value indicated that the predictors explain 68.91% (68.87% 
adjusted) of the variance of the POS costs, which suggests that 
the model is adjusted “moderately” to the data. Other results 
seeking the transformation of the dependent variable: analyzing 
the diagram of normal probability of the residuals for the model 
transformed logarithmically (Figure 3B), it is noted that “tail” still 
persist, although these are now thin. This shows that the principal 
premises of normality and constant variance in the errors are also 
not fulfilled. This led to seeking alternative models that permit 
better adjusting the data. According to the distribution, these 
suggest adjusting the exponential family, a necessary condition 
to explore generalized linear models.
“Statistical” results of the generalized linear model. Upon 
observing Table 1, from the previous model from formula 
[2], it presents for its estimations acceptable goodness-of-
fit indicators, small deviances, and minor Akaike Information 
Criterion (AIC), compared with the null model. However, we also 
have a deterministic indicator of 105% financial effectivity, that 
is, the model overestimates the cost observed by 5%.
Observing Figure 4 on residuals, it may be determined that there 
is a high percentage of affiliates to whom the model proposed 
overestimates the cost above cop$500,000.
Final results applicable to the health model
By analyzing the cost against the age variable, it was possible 
to identify a differential behavior when grouping the data by 
age ranges and by gender; this suggests a segmentation of the 
models, observed Figure 2, where the segments are constructed 
according to the variation coefficients estimated for each of 
them, whose behavior is quite similar or homogeneous.
Due to the high variability of costs by age groups, it was necessary 
to elaborate the segments according to the variation coefficients, 
which permitted improving the goodness of fit of the models by 
segments, compared with the AIC of the global model. Besides, 
significant improvement was observed in the effectivity of the 
mean cost (non- statistical indicator), which is 14.5% above that 
observed, with data from a subsequent period; estimating 95% 
CI of 2.5% and 37.9%, as average effectivity of the model with 
respect to the real cost.
In Table 2, and applying the antilogarithm to the coefficients 
of the model part one, whose practical interpretation may be 
assimilated to an association measurement, like the OR between 
the independent variables and costs per segments of age and 
gender, the GLM part two does not have a fit or adjustment test, 
which is why residual analysis is suggested (Figure 4).
Reference category as co-variable to explain the OR: for the 
qualitative variables, the reference category was coded as “1” 
in the database (last category) and in the table, it is described 
in parenthesis when it is not explicit in the name of the variable, 
as it is for risks where the reference category is having the risk.
Predictors increasing the medical cost of services are those that 
at the end of 12 months caused some variable cost due to the 
use of the service, showing in Table 2 those factors impacting 
positively upon the cost, like being a patient listed in the High-
Cost Account (7) HCA (VIH, CKD, rare, cancer) increased the cost 
between 4.9 and 6.5 times, compared with the non-HCA affiliates 
>19 years of age, and 2.0 times for those from 1 to 14 years of 
age. Having been classified with oncological risk increased the 
cost between 2.4 and 4.7 times for those from 1 to 14 years 
of age or who are >19 years of age, with the cost being higher 
for men from 15 to 18 years of age, with a weight of 31.6 times 
(here we basically find patients with leukemia and non-Hodgkin 
lymphoma). Being poly-consultant increased the cost by 10.6 
times for those <1 year of age, by 7.0 times for men from 19 to 
44 years of age, and by 5.1 times for those >45 years of age. The 
cost is higher in the Andean and Northeast regions, compared 
with the Pacific and Southern regions, for men between 15 and 
18 years of age by 1.6 and 1.3 times, respectively.
Model name Parameter Novelty Deviance AIC DF
Null model 0 It´s the null model 508,977.51 3,457,355.56 127,692,00
Quantitative with regions 14 The regions are included 257,628.52 3,345,237.08 127,658.00
Basics 8 It is the model with age, sex, regions 458,974.52 3,439,650.19 127,684.00
Basics + DRG 24 It is model with age, sex, DRG risk, more risk interactions 347,014,16 3,393,017.65 127,668.00
Qualitative with regions 34 The regions are included 295,191.77 3,366,847.28 127,658.00
AIC: Akaike Criterion, DF: Degrees of freedom; Null_model = Null model, DRG = Diagnostic Risk Groups.
Figure 3. Graphic of residual normality in the simple regression model for the 
POS cost (A), as well as for the logarithmically transformed model (B).
Table 1. Goodness-of-fit indicators for GLM models, considered globally for age with aggregation of factors.
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Factors that diminish the cost, shown in Table 2 in green: being 
a woman between 1 and 14 years of age diminishes the cost by 
17%, and for those >45 years of age on average diminishes by 
13%, compared with the cost of being a man for the respective 
group. Being new in the EPS, <1 year of age, from 19 to 44 years 
of age, and >45 years of age, age may be defined as a factor 
that favors the cost for beneficiaries from 1 to 18 years of age, 
given that this diminishes between 3% and up to 16%, but end 
up impacting the cost unfavorably in those >19 years of age. 
Another behavior highlighted in the reduction of the cost is that 
for the segments of affiliates >19 years of age, the medical cost 
reduces on average by 20% compared with the costs from the 
Pacific and Southern zone (departments from the Colombian 
Pacific Coast).
Factors with interaction
Being listed in the HCA and having a low- prevalence and high-
cost risk diminishes costs in half; it must be considered that, 
separately, these pathologies increase costs in those >45 years 
of age by 4.9 and 2.1 times, respectively. This same interaction 
effect occurs for patients listed with identification of health 
risks, according to that disposed in Resolution 4505 (6), that is, 
they are being intervened, once the risks are identified, in some 
health promotion and prevention program and, in turn, have 
been classified as poly-consultants; this junction diminishes 
costs by 30% for women from 19 to 44 years of age and for 
those >45 years of age. Again, it was observed that these factors, 
in separate and in added manner, increased costs by 1.4 and 
5.1 times, respectively. Thus, we have that in general where 
the interaction occurred a cost diminishing effect emerges; 
however, the opposite occurs for patients with COPD and cardio-
cerebrovascular risk, where a multiplicative effect was achieved, 
that is, besides the added increase of each of the pathologies, 
their interaction in a patient generates medical costs increase 
by 4.2 times.
Discussion
This research contributes to and enhances the theory de 
the models to explain costs in health insurance, offers 
“methodological changes” gathering different categories of 
analytic approaches, like that expressed in the work on the 
strategy to estimate costs in EuroHOPE (16). The design of 
policies focused on implementing the use of these models is 
recommended in the insurance carriers and state entities.
The Ministry of Health traditionally, since 1994 to date, 
has calculated this fee by using SLR models, which reach R² 
determination coefficients that range from 2% to 12% of the 
medical care cost, besides, does not fulfill the statistical criteria 
of model fit, that is, the regressor variables do not contribute 
significantly in the explanation of the cost. The situation of 
estimating a CPU with such a low determination coefficient and 
with so few variables included from a health – multi-systemic 
disease model, like that proposed by Lalonde (17), gives rise 
to underestimated or overestimated cost values with the 
subsequent economic implications and of viability of the model 
of health insurance in Colombia.
In specific modelling exercises to estimate medical costs, it is 
noted that the linear regression models underestimate medical 
costs and do not fulfill statistic criteria to estimate from these; 
this is the case of the CPU calculation, or payment fee to the EPS 
for the health expense. Due to this, the major strength in this 
study is the application of generalized linear models segmented 
by age groups, given that these shows better goodness of fit 
to the estimation of the costs, according to a user’s average 
accident rate.
Guaranteeing the EPS’s solvency is fundamental for each of 
the SGGSS sectors (15) because these entities are in charge of 
managing health risk. This is one of the intrinsic premises of 
most studies on the economy of health conducted in Colombia 
on its SGSSS. Many of these studies segment the population 
into specific risk groups with a combination of gender, age 
group, geographic location, and diagnostic group. Including the 
diagnosis permits estimating more precisely the distribution of 
costs of the EPS (18). The results of applying the model in two 
Figure 4. Model part 2. Residual vs. estimated values of the linear predictor  by segments of age  and gender. 
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parts, with one of them using GLM, shows an administrative 
plausibility in the majority of the coefficients of the independent 
variables. Understanding this term as an homologation to the 
term of causality in epidemiology, and which could be expressed 
herein in terms of the cultural acceptance within the health 
insurance of determinants of costs, for example, gender impacts 
upon the cost, exemplified in that women who use less services 
during non- reproductive years and that during these years, upon 
using more services (prenatal controls, hospitalizations due to 
deliveries) they begin to cost more than the men. Likewise, the 
model yielded plausible results when costs increased 4.1 times 
with comorbidities, like a patient with COPD risk + pathologies 
Table 2. Significant parameters of the Model according to Segments (the antilogarithm was applied to the 
coefficients of the original model).
Color code. Red: factors impacting upon the cost positively; Green: factors diminishing the cost; Orange: factors impacting 
minimally upon the cost in positive manner; and White: factors with no significant incidence on the POS cost.
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that increase cardio-cerebrovascular risk, like high blood 
pressure, diabetes, obesity, etc.
Another demonstration of the applicability of the model is 
constituted by the result showing that health costs have a 
“U” shaped behavior (Figure 3); high during the first year of 
life (secondary to the management of neonatal pathologies), 
descending until 15 years of age (school group and initial 
adolescent characterized by their scarce use of health services, 
and if these are used such are of low cost: general medicine 
consultation, vaccines, anticonception, others), and costs 
gradually start to increase until 65 years of age, as of which costs 
have an accelerated growth (onset of chronic, non-transmissible 
disease and – in many cases – of their chronic sequelae). This 
behavior is demonstrated by most insurance carriers globally.
For example, to calculate the CPU, almost all the results show 
that they vary significantly when including the health diagnosis 
(18). For this reason, not bearing in mind the epidemiological 
composition of the benefit plan insurers – EPS - for these 
calculations, may lead to defining economic results with very 
high insurance fees for the “healthier” population and very low 
for other EPSs with more ill-ridden population. This may occur 
because of the practice denominated skimming the market 
or “selection of risks” (18), that is, some insurance carriers 
limit affiliations of populations presumably of high demand of 
resources and, hence, in costs. Thereby, the authors consider 
that the disease burden should be included in modelling costs or 
in calculations for the CPU for the benefit plan insurers (EAPB) so 
that economic imbalance is avoided among them, which leads to 
confusing economic results for the SGSSS; some with large gains 
and others with large losses.
Since its beginning, the POS has been organized around a list of 
interventions and medications, and with respect to the estimation 
of the basic fee, which has been calculated annually in function 
of the records of activities, is adjusted with inflation, and since 
a few years back it has been adjusted by cities, where service 
offer problems could exist; in addition, it is adjusted ex-post by 
the High-Cost Account, given the presence of some catastrophic 
diseases.
Although we mention an insurance model, the fee calculated is 
based on the record of historical consumption of the previous 
year and does not effectively include any risk model or disease 
burden of the population of each EPS, given that beyond the 
adjustment made, a greater offer is obtained of services present 
in some cities, or in some catastrophic diseases.
The insurance carrier sector and the other sectors that construct 
the country’s economy need a model that explains better 
the population’s behavior and permits estimating adequately 
the fee to be paid into the system by each affiliate, based on 
epidemiological variables and not simply on the demographic 
variables. Thereby, classification models must be included 
according to the risks of each individual, and from these, it has 
been possible to demonstrate how the majority of the costs of 
an EPS concentrate on a small group of the population, Kaiser 
pyramid (19), as a scheme to explain the relationship between the 
number of affiliates and the total cost (19-21). The Kaiser pyramid 
is the model most-often used to classify the population into 
categories of intervention, depending on its level of complexity. 
It was developed by Kaiser Permanente in the United States in 
1945. On the base of the pyramid, Kaiser locates the healthy users 
of the population for which the promotion, prevention, and early 
and timely diagnosis of the disease are primordial. The second 
level classifies users who have some type of chronic disease, the 
achievement focuses on self-care, appropriate administration of 
medications, and education in healthy life habits. The third level 
has users classified as high cost or complex, who are set with risk 
programs guided by disease case management plans designed 
to mitigate inadequate use of specialized procedures and avoid 
hospital admissions and readmissions (20).
This type of risk-stratification model emerged because of 
imbalance in economic conditions. To the extent the insurance 
carriers began using it to develop different types of products 
and tariff structures according to its users’ risk profiles, these 
economic imbalances began to disappear. In health systems, risk 
adjustment and stratification permits the differential retribution 
of medical care services and activities and, above all, of the 
resources, this is done to avoid an unfeasibility of the system 
(21). In other words, the models of risk stratification permit 
identifying and managing patients who merit more specialized 
interventions, for example, elderly individuals with more than two 
diseases diagnosed. In these particular cases, the stratification 
seeks to avoid hospital admissions not programmed, optimize 
the assignment of resources, promote the patient’s self-care, 
prioritize the intensity of interventions at all levels.
Additionally, this methodological proposal could serve as the 
base to construct tools or instruments that permit continuous 
monitoring of the costs of health services demanded by the users 
of a health insurance carrier, without having the prior invoicing 
and only having the demographic factors, variables appertaining 
to the insurance business, and risk classification variable that 
aims to comply with one of the “Standards of monitoring and 
evaluation of the comprehensive networks of health services 
offer” that EPSs in Colombia must comply according to that 
disposed in Resolution 1441 of 2016 (22).
The accumulated distribution of health costs has a ‘peak’ at zero. 
This corresponds to an important percentage of individuals who 
have no variable medical costs in the POS; in the case of this 
study, this cost is constant through the figure of hiring through 
capitation of the basic level of care, that is, these people are 
managed by a third party at a fixed cost. For those people who 
do have medical costs, the distribution of costs is quite slanted to 
the right with the variance not constant. That is, there tends to 
be greater variability among the medical costs of the individuals 
when these are large than when these are small costs.
From the statistics point of view, we suggest modelling with 
other non- parametric alternatives, like the Generalized Additive 
Models – GAM (23,24), which would permit seeing the model 
integrated as a single one, not by segments, as well as without 
the possibility of estimating the magnitude with which the 
factors contribute to explaining costs.
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As an opportunity for future improvement of the present 
study, or as a starting point for future research, we could think 
of a classification that would consider the classification in the 
diagnostic-related groups (DRG), according to the number of 
contacts per types of services, as suggested by Vivas et al (25).
For improvement purposes, the model was carried out with data 
from 2012 to 2013, during the transition of the modification of 
the tariff plan in which some procedures and activities that were 
then considered outside the obligatory health plan (POS), as of 
2014 these were included in the POS. Similarly, other updates 
of this model must consider the inclusion of other independent 
variables, like time affiliated to the EPS, type of affiliation regime 
(contributive, subsidized), especially to recognize the theme of 
mobility, the users who go from being subsidized by the state 
(subsidized regime) when they are unemployed and which began 
in effect for Colombia as of 2014, according to Decree 3047 of 
2013 (26).
For pathologies whose risk coefficient is beneficial to the cost, it 
may be explained by an efficiency problem in the care opportunity 
of the patient and in the monitoring of the cost, which in this 
study was of one year. It may be that the intervention is late, and 
although the risk is present, affiliates initially do not consume, but 
in the long term we could evidence the effect of consumption.
Conclusions
Statistics: the “medical POS cost” is a variable not distributed 
formally and, although the transformation was made with 
Natural Logarithm, normality was not achieved, nor stability 
in the residual variance, which induces the search for other 
alternative methods to transform data, whose exploration 
and way of distributing these suggest a transformation of the 
exponential family; a necessary condition to model or treat the 
data through generalized linear models (GLM) segmented by age 
groups.
Due to the aforementioned, a good statistical model adjusted 
to the behavior of an insurance carrier’s cost is a GLM, which 
best fits to explain an abnormal variable, like the medical 
cost. Additionally, it included independent variables, like 
comorbidities and insurance variables, as well as the traditional 
sociodemographic variables (age, gender, and zone).
Applicable to a health model: the variables “favoring medical 
costs”, depending on the geographic region where the user is 
cared for are: being a woman in extreme groups of the vital 
cycle; having less than six months of affiliation to the EPS; being 
in wage range 2; belonging to regions different from the Pacific 
and South (except for males in age groups 15 to 18 years in the 
Andean and Northeast regions).
The variables associated most with increased costs are:
Patients with high-cost pathologies (CKD, HIV-AIDS, Cancer, 
rare diseases), being poly-consultant, having been reported as 
user with ex-ante risks and with current comorbidities, affiliates 
whose contributor is in wage range 3, being beneficiary for ages 
between 19 and 44 years, having COPD risks, risks of neoplastic 
origin, risk of mental illness, maternal perinatal users, CCRV risk, 
risk of chronic pathologies.
To validate the model, with 2014 budget data, and using the 
statistical model proposed for 2013, we have that the increase on 
the traditional model to estimate the mean cost for 2014, after 
indexing, was 12% above the value observed with an interval 
going from 2% above and 23% for the period comprised between 
October 2013 and September 2014.
Likewise, with a modelling exercise during a subsequent period 
and with data from 2015, effectiveness is achieved on the 
estimation performed by the model of 4.8% above the value 
observed.
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